Anuh Pharma Limited (ANUHPHR.BO)
INR 221.35
(-0.23%)
INR 221.35
(-0.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 6.47 Billion | 5.27 Billion | 4.86 Billion | 4.31 Billion | 3.06 Billion | 3.2 Billion |
| Cost of Revenue | 4.86 Billion | 4.01 Billion | 3.77 Billion | 3.29 Billion | 2.3 Billion | 2.42 Billion |
| Gross Profit | 1.6 Billion | 1.26 Billion | 1.08 Billion | 1.02 Billion | 767.96 Million | 777.24 Million |
| Operating Expenses | 263.04 Million | 815.55 Million | 717.6 Million | 716.92 Million | 532.45 Million | 447.85 Million |
| Selling, General and Administrative Expenses | 35.7 Million | 25.46 Million | 21.22 Million | 20.37 Million | 21.17 Million | 23.61 Million |
| Research and Development Expenses | - | 34.33 Million | 30.17 Million | 31.12 Million | 30.03 Million | 30.94 Million |
| Other Expenses | 120.97 Million | 629 Thousand | 496 Thousand | 803 Thousand | 1.77 Million | 1.14 Million |
| Cost and Expenses | 5.78 Billion | 4.83 Billion | 4.49 Billion | 4.01 Billion | 2.83 Billion | 2.87 Billion |
| Operating Income | 682.19 Million | 450.41 Million | 377.6 Million | 309.81 Million | 238.54 Million | 335.15 Million |
| Interest Expense | 9.57 Million | 2.18 Million | 9.6 Million | 14.94 Million | 7.92 Million | 1.71 Million |
| Income Tax Expense | 182.52 Million | 112.9 Million | 85.6 Million | 101.15 Million | 48.5 Million | 90.35 Million |
| Earnings before Tax | 783.09 Million | 474.7 Million | 391.22 Million | 385.51 Million | 191.55 Million | 324.01 Million |
| Net Income | 600.57 Million | 361.79 Million | 305.61 Million | 284.36 Million | 143.05 Million | 233.65 Million |
| Earnings Per Share Basic | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 4.66 |
| Earnings Per Share Diluted | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 4.66 |
| Weighted Average Shares Outstanding | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million |
| Gross Margin | 0.25 | 0.24 | 0.22 | 0.24 | 0.25 | 0.24 |
| EBIT Margin | 0.14 | 0.10 | 0.10 | 0.11 | 0.10 | 0.10 |
| Profit Margin | 0.09 | 0.07 | 0.06 | 0.07 | 0.05 | 0.07 |
| EBITDA | 878.5 Million | 579.16 Million | 526.61 Million | 556.57 Million | 274.46 Million | 346.61 Million |
| Earnings Before Tax Margin | 0.11 | 0.09 | 0.08 | 0.07 | 0.08 | 0.10 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.37 Billion | 6.47 Billion | 1.63 Billion | 1.72 Billion | 1.49 Billion | 1.61 Billion |
| Cost of Revenue | 1.12 Billion | 5.14 Billion | 1.27 Billion | 1.25 Billion | 1.11 Billion | 1.29 Billion |
| Gross Profit | 256.92 Million | 1.32 Billion | 360.71 Million | 463.09 Million | 384.71 Million | 323.27 Million |
| Operating Expenses | 170.03 Million | 658.03 Million | 190.75 Million | 245.19 Million | 226.58 Million | 203.6 Million |
| Selling, General and Administrative Expenses | 170.03 Million | - | 190.75 Million | 172.77 Million | 158.7 Million | 135.8 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 37.19 Million | 120.97 Million | 28.22 Million | 36.57 Million | 21.48 Million | 34.69 Million |
| Cost and Expenses | 1.29 Billion | 5.8 Billion | 1.46 Billion | 1.5 Billion | 1.33 Billion | 1.49 Billion |
| Operating Income | 86.88 Million | 665.65 Million | 169.96 Million | 217.9 Million | 158.12 Million | 119.66 Million |
| Interest Expense | 1.41 Million | 3.53 Million | 1.01 Million | 1.41 Million | 885 Thousand | 224 Thousand |
| Income Tax Expense | 27.57 Million | 182.52 Million | 43.59 Million | 61.92 Million | 40.39 Million | 36.61 Million |
| Earnings before Tax | 122.66 Million | 783.09 Million | 197.17 Million | 253.05 Million | 178.73 Million | 154.13 Million |
| Net Income | 95.09 Million | 600.57 Million | 153.57 Million | 191.13 Million | 138.33 Million | 117.52 Million |
| Earnings Per Share Basic | 1.90 | - | 3.06 | 3.81 | 2.76 | 2.35 |
| Earnings Per Share Diluted | 1.90 | - | 3.06 | 3.81 | 2.76 | 2.35 |
| Weighted Average Shares Outstanding | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million | 50.11 Million |
| Gross Margin | 0.19 | 0.20 | 0.22 | 0.27 | 0.26 | 0.20 |
| EBIT Margin | 0.08 | - | 0.12 | 0.16 | 0.13 | 0.11 |
| Profit Margin | 0.07 | 0.09 | 0.09 | 0.11 | 0.09 | 0.07 |
| EBITDA | 105.68 Million | - | 192.23 Million | 276.49 Million | 201.07 Million | 174.44 Million |
| Earnings Before Tax Margin | 0.06 | 0.10 | 0.10 | 0.13 | 0.11 | 0.07 |
CCT
GLOW
TDRRF
NIMU
001515
PAYOW